Consolidated Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses
Research and development	$ 63,300,000	$ 37,800,000	$ 129,100,000	$ 65,300,000
General and administrative	118,100,000	42,400,000	162,200,000	80,200,000
Other warrant expense	0	0	2,100,000	0
Total operating expenses	181,400,000	80,200,000	293,400,000	145,500,000
Loss from operations	(181,400,000)	(80,200,000)	(293,400,000)	(145,500,000)
Other (expense) income, net	(6,600,000)	8,000,000.0	(9,300,000)	14,500,000
Interest income, net	4,100,000	500,000	5,700,000	100,000
Loss before income taxes	(183,900,000)	(71,700,000)	(297,000,000.0)	(130,900,000)
Income tax expense	(200,000)	0	(200,000)	0
Net loss	$ (184,100,000)	$ (71,700,000)	$ (297,200,000)	$ (130,900,000)
Net loss per share, basic (in dollars per share)	$ (0.73)	$ (0.30)	$ (1.19)	$ (0.55)
Net loss per share, diluted (in dollars per share)	$ (0.73)	$ (0.30)	$ (1.19)	$ (0.55)
Weighted-average shares outstanding, basic (in shares)	251,018,612	238,062,232	249,156,920	238,927,711
Weighted-average shares outstanding, diluted (in shares)	251,018,612	238,062,232	249,156,920	238,927,711